| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Nov―12 |
Differential Immunogenicity of mRNA-based and Inactivated Virus COVID-19 Vaccines in Patients with Inflammatory Rheumatic Disease - A Prospective Study up to 12 Months Post-3rd Dose |
Nga Sze Wong, Isaac T Cheng, Tracey Yu, Vivien Chan, Tena Li, Lai-Shan Tam, et al. (+2) Paul KS Chan, Ho So |
| 2 |
[GO] |
2024―Nov―12 |
An Observational Cohort Study to Estimate the Durability of Humoral Immune Responses to Vaccination with ChAdOx1 nCoV-19 and the BBV152 in Adult Patients with Autoimmune Rheumatic Diseases (AIRD) |
Ravi Kumar, Ramya Madhavan, John Mathew, Ashish Mathew, Ruchika Goel |
| 3 |
[GO] |
2023―Jul―06 |
Managing a Case of Refractory Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Dermatomyositis with Recent COVID-19 Infection |
Cheryl Chun Man Ng, Alexander Moon Ho Leung |
| 4 |
[GO] |
2023―Feb―18 |
Risk of Exacerbation of Rheumatic Disease after COVID-19 Vaccination |
Amy Cheung Chung Ting, Ho Yin Chung, Shirley Chiu Wai Chan, Vanessa Ip Yan Lam |
| 5 |
[GO] |
2021―May―05 |
The Hong Kong Society of Rheumatology Consensus Recommendations for COVID-19 Vaccination in Adult Patients with Autoimmune Rheumatic Diseases |
Ho So, Chi Chiu Mok, Ronald Man Lung Yip |
| 6 |
[GO] |
2020―May―31 |
COVID-19 and Rheumatic Diseases: Practical Issues |
Ho So, Chi Chiu Mok |
| 7 |
[GO] |
2020―Apr―19 |
Rheumatology Drugs and COVID-19 |
Chi Chiu Mok |
